📋 Tender Overview
Amazon Web Services Inc. AWS an Amazon.com Inc. company announced that Gilead Sciences Inc. a biopharmaceutical company advancing innovative medicines to prevent and treat life-threatening diseases has selected AWS as its preferred cloud provider. Innovating on AWS and with the help of AWS experts and partners in healthcare and life sciences Gilead provides its data scientists with the latest advances in machine learning and analytics. These capabilities fuel data-driven decision making across the organizationfrom biomarker discovery through manufacturing and clinical trial recruitmentand deliver insights that can help Gilead refine its drug pipeline. The company also relies on AWS to host all workloads for its enterprise resource planning ERP transformation project to implement SAP S4HANA.With AWS as our preferred cloud provider our researchers can use AWSs portfolio of services to gain the insights agility and security needed to deliver new medicines at speed and treat the individual according to their unique needs not just the disease said Marc Berson Senior Vice President and Chief Information Officer at Gilead. AWSs performance infrastructure and scale are the foundations on which we will complete our ERP transformation and become a more efficient agile secure and data-driven business in the cloud.Gilead is reimagining its bioinformatics compute infrastructure in the worlds leading cloud. The use of AWSs compute machine learning and database capabilities will support the analysis and integration of diverse genomics imaging and experimental datasets to support breakthroughs in how Gilead diagnoses and treats diseases. For instance by securely analyzing deidentified patient genomic data at scale on AWS to reveal patterns Gilead can uncover insights on how people living with cancer respond to existing therapeutic options potentially accelerating the discovery of new treatments.Additionally in its IT organization Gilead uses AWS to host all workloads for its ERP transformation project to implement SAP S4HANA. These systems support business-critical processes in areas such as supply chain finance operations and commercial sales across all therapeutic areas and business units. Running these processes on AWS provides the foundation for Gileads implementation of SAP S4HANA. It also helps the company shorten hardware refresh cycles increase testing and deployment agility and gain visibility to improve business planning.This is Gileads first implementation of production-scale ERP systems in the cloud and AWS provides the companys IT transformation team with scalable secure and high-performing infrastructure. Working alongside AWS Gilead will integrate its SAP environments with a wide range of advanced AWS technologies in areas such as analytics and machine learning uncovering business value and driving innovation. Moving forward with AWS as the foundation of its new cloud-based SAP environment the company will use a variety of Amazon Elastic Compute Cloud Amazon EC2 instance types including X1 and X1e instances built for high-performance databases in-memory databases and other memory-intensive enterprise applications to run ERP workloads more efficiently.In addition Gilead has moved more than 50 of its data center footprint to AWS over the past 12 months through an accelerated cloud migration program with AWS Professional Services. The company also plans to migrate hundreds of applications to AWS which include critical applications that support industry good practices GxP guidelines and regulations in areas like drug manufacturing storage and distribution. As a result Gilead is accelerating its plans to upgrade its IT operations with AWS while avoiding upfront costs to refresh hardware and the sustained costs of running an always on on-premises IT landscape provisioned for peak use. As an additional element of the migration the company is building an automated disaster recovery landscape in AWS. Doing so allows Gilead IT to optimize and scale its disaster recovery processes in the cloud to enhance resiliency.With the help of AWS Professional Services and AWS experts in healthcare and life sciences Gilead research and development teams are looking at ways to innovate in the cloud. They are taking an agile product development approach that uses microservices to optimize and automate operational processes throughout the company and constructing new data architectures to uncover new insights more easily. Through the collaboration Gilead aims to transform priority areas like clinical program and study design patient experience and centralized statistical adaptive monitoring which helps Gilead quickly identify and address potential issues related to the management of clinical trials.Gilead was also one of the first users of AWS for Health an offering of curated AWS services and AWS Partner Network APN solutions now used by thousands of healthcare and life sciences customers globally. AWS for Health provides proven and easily accessible capabilities that help organizations increase the pace of innovation unlock the potential of health data and develop more personalized approaches to therapeutic development and care across 16 critical solution areas in healthcare genomics and biopharma.Gilead uses the proven performance of the worlds leading cloud to innovate scale and deliver powerful therapies for diseases like HIV and cancer as well as advance standards for precision medicine. By streamlining their IT operations with AWS and taking advantage of our AWS for Health offerings Gilead has the ability to continuously refine its approach to clinical trials drug development manufacturing and distribution said Matt Garman Senior Vice President of Sales and Marketing at Amazon Web Services Inc.
